 Home > Medical News >

Medical Research Articles

Jansen's innovative drug Stelara (ustekinumab) achieved positive results in Phase 3 clinical trials treating UC adult patients

 Time of Update: 2020-06-11

dextroamphetamine 15 mg endometriosis clinical trial mobic 15 mg quality safety drug induced

UC and Crohn's disease (CD) are two of the most common inflammatory bowel disease (IBD), both chronic, recurrent, and self-relieving inflammatory progressive digestive tract (GI) disease today, Jan
FDA approves neurotoxin product Xeomin for treatment of chronic salivation in adult patients

 Time of Update: 2020-06-11

als disease meaning plum a pump om group inc unit rate change amyotrophic sclerosis

salivation is mainly manifested in drooling, a common symptom in patients with neurological disorders, including Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), cerebral palsy (CD), a
FDA approves update of prescription label information for ammo MM-targeted drug Kyprolis (carzofilmib)

 Time of Update: 2020-06-11

metaxalone generic name antivert drug myalgic encephalomyelitis treatment psk 9 inhibitor fluorouracil treatment

recently, Amgen announced that the U.S Food and Drug ( FDA ( FDA) has approved the multiple myeloma (MM) targeted drug Kyprolis (carfilzomib) prescription label information update, including ph
FDA approves Lilly Alimta (injection pemele) with a new indication

 Time of Update: 2020-06-11

cancer cell proliferation supplements fda approved cell therapy manufacturing keytruda sales fda approval search

recently, the U.S Pharmaceuticals announced that the U.S Food and Drug ( FDA ( ) has approved alimta (injection-based pemephore) combined carboplatin and Mercado-1 immunotherapy Keytruda (Pembr
Gileaddi Paveso Phosphorous Bwe (trade name Harvoni) is about to be approved for listing in China

 Time of Update: 2020-06-11

use compound microscope which spf use hypertension treatment drugs 1 3 simplified parainfluenza 3 treatment

recently, Gileaddi Paeveso phosphorous buwe tablets (trade name Harvoni) in China's import listing application entered the "in the approval" stage, this hepatitis C drug will soon be approved in the
FDA approves Braftovi capsule synthe mektovi tablets for treatment of melanoma patients

 Time of Update: 2020-06-11

abbvie studies epinephrine pathway cancer differentiation plaskolite columbus ohio single cell cancer

recently, Array BioPharma (announced that the U.S Food and Drug ( FDA () has approved Braftovi (binimetinib), a MEK inhibitor) combined with Mektovi (encorafenib, a BRAF inhibitor) tablet for a
The listing application for the new class 1 drug Malayacid pyridorate and tablets of Hengrui Pharmaceuticals has been reviewed

 Time of Update: 2020-06-11

stimulant drugs list abbott product list fda approved biosimilars hla class 1 adderall drug class

recently, C FDA (official website information shows that Jiangsu Hengrui Pharmaceutical (class new drug (Malay acid pyrideinandini and tablets have been reviewed, is expected to be approved for
Application for FDA approval for supplementary biologics for wet age macular degeneration injection EYLEA

 Time of Update: 2020-06-11

western blot test cow age semaglutide clinical trials gastroccult test 1 2 3 4

AMD is a common age-related eye disease common lying in people over 50 years of age and is the leading cause of vision loss and irreversible vision loss recently, Regeneron Pharmaceuticals announce
FDA approves Rituxan for treatment of adult patients with moderate to severe normal herpes

 Time of Update: 2020-06-11

3 methoxybenzoic acid ia 2 antibody 1 2 3 trichloropropane conducting 3 4 fda approved drugs

recently, Swiss Pharmaceuticals announced that the U.S Food and Drug ( FDA ( FDA) has approved the treatment of adult patients with moderate to severe normal type of osteophlys (PV) with ritu
FDA approves new adaptation of INVOKANA

 Time of Update: 2020-06-11

1 2 dibromoethane type 2 fibers 3 8 1 2 drugs com drug interactions renin inhibitor drugs

recently, Johnson and Johnson's Janssen Pharmaceutical (Inc.) (The U.S FDA (approved INVOKANA, canagliflozin) new adaptation to reduce the risk of cardiovascular heart disease, stroke or death
FDA approves Mercado PD-1 tumor immunotherapy Keytruda for treatment of hepatocellular carcinoma patients

 Time of Update: 2020-06-11

libtayo fda approval singulair generic name ceftriaxone generic name open end wrench set cetirizine generic name

recently, Mercado announced that the U.S FDA (approved its PD-1 tumor immunotherapy Keytruda (Chinese commodity name: Creeda, generic name: Pablo Pearlmono) a new indication for patients with hepa
FDA approves NEW drug application for JAZZ Pharmaceuticals to repair Xyrem oral solution

 Time of Update: 2020-06-11

morphine oral solution sodium chloride safety amoxicillin oral suspension fda nutrition facts concerta maximum dose

seizure sleep disorder is a long-term neurological disease in which patients have reduced their ability to regulate sleep/wake cycles Recently, the JAZZ Pharmaceutical s on announced that the u.S
FDA approves Mercado-heavy immunotherapy Keytruda (pembrolizumab) to treat patients with advanced cervical cancer

 Time of Update: 2020-06-11

cd 1 mice 3 4 7 8 nexplanon fda approved future cancer treatment anti ccp antibody

recently, the (MSD) of The of Mersadon announced that the U.S FDA approve its heavy immunotherapy, The Keytruda, to treat patients with advanced cervical cancer Keytruda Keytruda is a monoclon
Roche's heavy-duty drug for type A haemophilia, Hemlibra, gets FDA approval

 Time of Update: 2020-06-11

rheumatoid factor 20 surface solutions group heavy duty transmission heavy duty trolley antibody drug conjugate

type A haemophilia is a serious genetic disease healthy (when a person bleeds, a clotting protein called factor VIII brings together factor IXa and factor X, triggering a clotting process that hel
Merck has partnered with Xi'an Janssen to launch an innovative adult type 2 diabetes treatment with a new drug, Acoad®

 Time of Update: 2020-06-11

swimmer body type vaccines population control 2 4 products new age cryo blood urine liver

China has 114 million people with diabetes, the highest number in the world, according to the 2017 Diabetes Map released by the International Diabetes Federation According to the 2017 edition of Chi
FDA grants ABI-H0731 fast-track determination for treatment of HBV infection patients

 Time of Update: 2020-06-11

ricca chemical company lyme test results glyphosate half life standard addition trazodone drug test

recently, the U.S FDA , which has been awarded a drug for the treatment of patients with chronic hepatitis B virus (HBV) infection, announced ABI-H0731, a core protein inhibitor for Assembly B
Veatonite diet drug Belviq helps people lose weight and stay long-term

 Time of Update: 2020-06-11

acarbose weight loss 1 3 propanesultone mass effect definition 3 way valve ultrasound weight loss

recently, research has shown that Eisai's company , a weight-loss drug, Belviq, can help people lose weight and maintain it for a long time without increasing the risk of heart disease findings w
Quadripling influenza virus lysatis vaccine approved for market in China

 Time of Update: 2020-06-11

application world market savannah helium 3 price what 3 8 advanced process control

yesterday, the State Drug Administration issued a message: four-price influenza virus cracking vaccine in China was approved for market sources said there had been a marked increase in influenza ou
Concentric Analgesics' new drug ca-008 for postoperative pain is recognized by FDA for breakthrough therapies

 Time of Update: 2020-06-11

mohs surgery recovery ipratropium drug class benzodiazepine drug class endometriosis pain relief safe

Today, Co ncentric Bio medicine (Inc.) (announced that it is the new drug (recognized by the U.S FDA ( a breakthrough therapy the CA-008 developed by the CA- ncentric Analgesics is a non-opi
Aishi and Purdue Pharmaceuticals submit a new drug application to the FDA

 Time of Update: 2020-06-10

drug buyers guide mucinex drug class dopamine drug bacteria battling drug tianeptine drug test

recently, Japanese drugmaker Eisai and Purdue Pharmaceutical http:// , the fda and drug, have submitted a application for new drug (http:// (NDA) to the u.S Food and Drug http:// (http://

Go to Page

Medical Research Articles

Jansen's innovative drug Stelara (ustekinumab) achieved positive results in Phase 3 clinical trials treating UC adult patients

FDA approves neurotoxin product Xeomin for treatment of chronic salivation in adult patients

FDA approves update of prescription label information for ammo MM-targeted drug Kyprolis (carzofilmib)

FDA approves Lilly Alimta (injection pemele) with a new indication

Gileaddi Paveso Phosphorous Bwe (trade name Harvoni) is about to be approved for listing in China

FDA approves Braftovi capsule synthe mektovi tablets for treatment of melanoma patients

The listing application for the new class 1 drug Malayacid pyridorate and tablets of Hengrui Pharmaceuticals has been reviewed

Application for FDA approval for supplementary biologics for wet age macular degeneration injection EYLEA

FDA approves Rituxan for treatment of adult patients with moderate to severe normal herpes

FDA approves new adaptation of INVOKANA

FDA approves Mercado PD-1 tumor immunotherapy Keytruda for treatment of hepatocellular carcinoma patients

FDA approves NEW drug application for JAZZ Pharmaceuticals to repair Xyrem oral solution

FDA approves Mercado-heavy immunotherapy Keytruda (pembrolizumab) to treat patients with advanced cervical cancer

Roche's heavy-duty drug for type A haemophilia, Hemlibra, gets FDA approval

Merck has partnered with Xi'an Janssen to launch an innovative adult type 2 diabetes treatment with a new drug, Acoad®

FDA grants ABI-H0731 fast-track determination for treatment of HBV infection patients

Veatonite diet drug Belviq helps people lose weight and stay long-term

Quadripling influenza virus lysatis vaccine approved for market in China

Concentric Analgesics' new drug ca-008 for postoperative pain is recognized by FDA for breakthrough therapies

Aishi and Purdue Pharmaceuticals submit a new drug application to the FDA